Enzalutamide 40 mg

Enzalutamide 40 mg – Targeted Oral Therapy for Advanced Prostate Cancer

Enzalutamide 40 mg is a next-generation androgen receptor inhibitor used for the treatment of advanced prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC), non-metastatic CRPC, and metastatic castration-sensitive prostate cancer (mCSPC). It is a highly effective, FDA-approved oral medication that works by inhibiting androgen receptor signaling, which plays a crucial role in the growth and spread of prostate cancer cells.

How It Works:

Unlike traditional hormone therapies that reduce androgen production, Enzalutamide directly blocks the androgen receptor and prevents testosterone and other male hormones from binding to it. This prevents cancer cell activation and proliferation, even in the presence of low androgen levels. Enzalutamide is particularly beneficial for patients whose prostate cancer continues to progress despite ongoing hormone therapy.

Indications:

• Metastatic castration-resistant prostate cancer (mCRPC)

• Non-metastatic CRPC (high risk of metastasis)

• Metastatic castration-sensitive prostate cancer (mCSPC)

• As part of combination therapy with androgen deprivation therapy (ADT)

Key Benefits:

• Each capsule contains 40 mg of Enzalutamide

• Oral once-daily dosing no injections required

• Targets androgen receptor activity at multiple levels

• Helps delay cancer progression and improves survival

• Reduces tumor growth and prostate-specific antigen (PSA) levels

• Suitable for long-term use under medical supervision

• Often used in combination with ADT or LHRH agonists

Dosage and Administration:

The usual dose is 160 mg once daily (4 capsules of 40 mg), with or without food. Enzalutamide should be taken at the same time each day. Patients should not stop or alter the dose without consulting a healthcare provider. Regular monitoring of PSA levels, liver function, and side effects is recommended.

Common side effects may include fatigue, hot flashes, back pain, high blood pressure, and falls. Rare but serious effects include seizures and cardiovascular complications in predisposed individuals.

Enzalutamide 40 mg offers a powerful, convenient solution in the fight against advanced prostate cancer. Available now at QuickRxHub, you can expect secure ordering, confidential delivery, and global access to trusted oncological care.